ELDER BIOMEDA EAD
Elder Pharma to enter new therapeutics areas to drive growthThe company plans to further strengthen its in-licence portfolio and increase its presence in CNS therapeutic and cardio-vascular segments.
Elder Pharma to focus on anti-infectives, international marketThe company intends to increase its presence in the UK & Europe through its wholly owned subsidiaries, NeutraHealth PLC & Elder Biomeda EAD...
- Load More